Vaccitech (VACC) Competitors

Vaccitech (NASDAQ:VACC) and Procaps Group (NASDAQ:PROC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

Which has better earnings & valuation, VACC or PROC?

Procaps Group has higher revenue and earnings than Vaccitech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vaccitech	$13.42M	3.04	$5.34M	-$1.43	-0.74
Procaps Group	$409.92M	0.26	$42.54M	N/A	N/A

Does the media favor VACC or PROC?

In the previous week, Vaccitech's average media sentiment score of 0.00 equaled Procaps Group'saverage media sentiment score.

Company	Overall Sentiment
Vaccitech	Neutral
Procaps Group	Neutral

Which has more volatility and risk, VACC or PROC?

Vaccitech has a beta of -0.4, suggesting that its share price is 140% less volatile than the S&P 500. Comparatively, Procaps Group has a beta of -0.05, suggesting that its share price is 105% less volatile than the S&P 500.

Is VACC or PROC more profitable?

Procaps Group has a net margin of 0.00% compared to Vaccitech's net margin of -409.18%. Procaps Group's return on equity of 0.00% beat Vaccitech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vaccitech	-409.18%	-23.41%	-20.85%
Procaps Group	N/A	N/A	N/A

Do institutionals & insiders believe in VACC or PROC?

26.1% of Vaccitech shares are owned by institutional investors. 6.0% of Vaccitech shares are owned by insiders. Comparatively, 19.9% of Procaps Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Procaps Group beats Vaccitech on 7 of the 9 factors compared between the two stocks.